Chemistry: analytical and immunological testing – Peptide – protein or amino acid
Reexamination Certificate
2003-07-17
2008-10-28
Nashed, Nashaat T. (Department: 1656)
Chemistry: analytical and immunological testing
Peptide, protein or amino acid
C702S027000
Reexamination Certificate
active
07442554
ABSTRACT:
A binding site in nuclear hormone receptors is described and its structural coordinates are provided. The invention provides machine-readable data storage media comprising structure coordinates of Site II and computer systems comprising the machine-readable data storage media. The invention provides methods used in the design and identification of ligands of Site II and of modulators of nuclear hormone receptors. The invention provides ligands of Site II, modulators of NHRs, pharmaceutical compositions comprising modulators of NHRs, methods of modulating NHRs, and methods of treating diseases by administering modulators of an NHR. Also provided are methods of designing mutants, mutant NHRs, Site II binding assays, and models of Site II.
REFERENCES:
patent: 5759785 (1998-06-01), Tsai et al.
patent: 5856116 (1999-01-01), Wilson et al.
patent: 6236946 (2001-05-01), Scanlan et al.
patent: 6965850 (2005-11-01), Baxter et al.
patent: 2005/0181362 (2005-08-01), Apolito et al.
patent: 1375517 (2004-02-01), None
patent: WO 00/52050 (2000-09-01), None
patent: WO 03/015692 (2003-02-01), None
patent: WO 03/090666 (2003-06-01), None
patent: WO 2004/009017 (2004-01-01), None
Arriza, J.L. et al., “Cloning of Human Mineralocorticoid Receptor Complementary DNA: Structural and Functional Kinship with the Glucocorticoid Receptor”, Science, vol. 237, pp. 268-275 (1987).
Baldwin, Jr., A.S., “The transcription factor NF-κB and human disease”, The Journal of Clinical Investigation, vol. 107, No. 1, pp. 3-6 (2001).
Bamberger, C.M. et al., “Glucocorticoid Receptor β, a Potential Endogenous Inhibitor of Glucocorticoid Action in Humans”, The Journal of Clinical Investigation, vol. 95, pp. 2435-2441 (1995).
Bledsoe, R.K. et al., “Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator Recognition”, Cell, vol. 110, pp. 93-105 (2002).
Bourguet, W. et al., “Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α”, Nature, vol. 375, pp. 377-382 (1995).
Brandon, D.D. et al., “Genetic variation of the glucocorticoid receptor from a steroid-resistant primate”, Journal of Molecular Endocrinology, vol. 7, pp. 89-96 (1991).
Caldenhoven, E. et al., “Negative Cross-Talk between ReIA and the Glucocorticoid Receptor: A Possible Mechanism for the Antiinflammatory Action of Glucocorticoids”, Molecular Endocrinology, vol. 9, No. 4, pp. 401-412 (1995).
Chakravarti, D. et al., “Role of CBP/P300 in nuclear receptor signalling”, Nature, vol. 383, pp. 99-103 (1996).
Coghlan, M.J. et al., “Synthesis and Characterization of Non-Steroidal Ligands for the Glucocorticoid Receptor: Selective Quinoline Derivatives with Prednisolone-Equivalent Functional Activity”, J. Med. Chem., vol. 44, pp. 2879-2885 (2001).
Da Silva, J.A. et al., “Optimizing Glucocorticoid Therapy in Rheumatoid Arthritis”, Neuroendocrine Mechanisms in Rheumatic Disease, Rheumatic Disease Clinics of North America, vol. 26, No. 4, pp. 859-880 (2000).
Danielsen, M. et al., “The mouse glucocorticoid receptor: mapping of functional domains by cloning, sequencing and expression of wild-type and mutant receptor proteins”, The EMBO Journal, vol. 5, No. 10, pp. 2513-2522 (1986).
Darimont, B.D. et al., “Structure and specificity of nuclear receptor-coactivator interactions”, Genes & Development, vol. 12, pp. 3343-3356 (1998).
Diamond, M.I. et al., “Transcription Factor Interactions: Selectors of Positive or Negative Regulation from a Single DNA Element”, Science, vol. 249, pp. 1266-1272 (1990).
Eisenmann, G. et al., “Quand Les Cellules Scintillent”, Le Technoscope De Biofutur, No. 151, p. 8 (1995).
Elmore, S.W. et al., “Nonsteroidal Selective Glucocorticoid Modulators: the Effect of C-5 Alkyl Substitution on the Transcriptional Activation/Repression Profile of 2,5-Dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]1uinolines”, J. Med. Chem., vol. 44, pp. 4481-4491 (2001).
Evans, R.M., “The Steroid and Thyroid Hormone Receptor Superfamily”, Science, vol. 240, pp. 889-895 (1988).
Firestein, G.S. et al., “Signal Transduction and Transcription Factors in Rheumatic Disease”, Arthritis & Rheumatism, vol. 42, No. 4, pp. 609-621 (1999).
Francis, G.A. et al., “Nuclear Receptors and the Control of Metabolism”, Annu. Rev. Physiol., vol. 65, pp. 261-311 (2003).
Giguère, V. et al., “Functional Domains of the Human Glucocorticoid Receptor”, Cell, vol. 46, pp. 645-652 (1986).
Giguère, V. et al., “Identification of a new class of steroid hormone receptors”, Nature, vol. 331, pp. 91-94 (1988).
Giguère, V. et al., “Orphan Nuclear Receptors: From Gene to Function”, Endocrine Reviews, vol. 20, No. 5, pp. 689-725 (1999).
Grange, T. et al., “In vivo analysis of the model tyrosine aminotransferase gene reveals multiple sequential steps in glucocorticoid receptor action”, Oncogene, vol. 20, pp. 3028-3038 (2001).
Green, S. et al., “Human oestrogen receptor cDNA: sequence, expression and homology tov-erb-A”, Nature, vol. 320, pp. 134-139 (1986).
Greene, M.E. et al., “Isolation of the Human Peroxisome Proliferator Activated Receptor Gamma cDNA: Expression in Hemotopoietic Cells and Chromosomal Mapping”, Gene Expression, vol. 4, pp. 281-299 (1995).
Greschik, H. et al., “Structural and Functional Evidence for Ligand-Independent Transcriptional Activation by the Estrogen-Related Receptor 3”, Molecular Cell, vol. 9, pp. 303-313 (2002).
Hager, L.J. et al., “Transcriptional regulation of mouse liver metallothionein-I gene by glucocorticoids”, Nature, vol. 291, pp. 340-342 (1981).
Hofmann, T.G. et al., “Various glucocorticoids differ in their ability to induce gene expression, apoptosis and to repress NF-κB-dependent transcription”, FEBS Letters, vol. 441, pp. 441-446.
Hollenberg, S.M. et al., “Primary structure and expression of a functional human glucocorticoid receptor cDNA”, Nature, vol. 318, pp. 635-641 (1985).
Huang, X. et al., “Elucidating the Inhibiting Mode of AHPBA Derivatives against HIV-1 Protease and Building Predictive 3D-QSAR Models”, J. Med. Chem., vol. 45, pp. 333-343 (2002).
Jonat, C. et al., “Antihumor Promotion and Antiinflammation: Down-Modulation of AP-1 (Fos/Jun) Activity by Glucocorticoid Hormone”, Cell, vol. 62, pp. 1189-1204 (1990).
Jones, D.C. et al., “Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPARα) Is Expressed in Resting Murine Lymphocytes”, The Journal of Biological Chemistry, vol. 277, No. 9, pp. 6838-6845 (2002).
Kalkhoven, E. et al., “Negative Interaction between the RelA(p65) Subunit of NF-κB and the Progesterone Receptor”, The Journal of Biological Chemistry, vol. 271, No. 11, pp. 6217-6224 (1996).
Kallio, P.J. et al., “Androgen Receptor-Mediated Transcriptional Regulation in the Absence of Direct Interaction with a Specific DNA Element”, Molecular Endocrinology, vol. 9, No. 8, pp. 1017-1028 (1995).
Kamei, Y. et al., “A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors”, Cell, vol. 85, pp. 403-414 (1996).
Kauppi, B. et al., “The Three-dimensional Structures of Antagonistic and Agonistic Forms of the Glucocorticoid Receptor Ligand-binding Domain”, The Journal of Biological Chemistry, vol. 278, No. 25, pp. 22748-22754 (2003).
Keightley, M.-C. et al., “Unique Sequences in the Guinea Pig Glucocorticoid Receptor Induce Constitutive Transactivation and Decrease Steroid Sensitivity”, Molecular Endocrinology, vol. 8, No. 4, pp. 431-439 (1994).
Keller, E.T. et al., “Inhibition of NF κB Activity through Maintenance of IκB&
Doweyko Arthur M. P.
Nadler Steven G.
Bristol--Myers Squibb Company
Handler Melissa
Lee Jae W
Nashed Nashaat T.
LandOfFree
Compositions and methods involving glucocorticoid receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods involving glucocorticoid receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods involving glucocorticoid receptor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4002270